计算生物学
生物
纳米技术
计算机科学
生化工程
工程类
材料科学
作者
Yvonne A. Nagel,Adrian Britschgi,Antonio Ricci
出处
期刊:Wiley eBooks
[Wiley]
日期:2021-02-26
卷期号:: 47-85
被引量:6
标识
DOI:10.1002/9783527826872.ch2
摘要
Targeted protein degradation is becoming a weapon of choice against targets considered heretofore “undruggable.” Whereas most small molecules inhibit a protein by blocking its active site, degraders or proteolysis-targeting chimeras (PROTACs) and other protein destabilizers harness the cell's own recycling machinery to remove the entire protein. It is an exciting time for this new technology that currently transitions from laboratory to clinic. In this book chapter, we will give a brief overview starting from the first to the latest generation of degraders that are just hitting the clinic and discuss their potential as a new therapeutic modality. Furthermore, we will highlight the latest developments in this rapidly evolving area and outline learnings for design and synthesis of degraders. Finally, we will discuss future perspectives and the potential next generation of degraders as well as related technologies, which harness the cell's proteasomal machinery, such as molecular glue-like degraders or monovalent degraders.
科研通智能强力驱动
Strongly Powered by AbleSci AI